Delivery Order SPE2DR25D1100-SPE2DR26FDR7D

<p>The Defense Logistics Agency issued a $11,261.28 delivery order to Amerisourcebergen Drug Corp on April 7, 2026, for 20,000 units of PHESGO 600–600 mg in 10 ml vials, with an ultimate completion date of April 28, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is issued under firm fixed-price terms with no set-aside.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 19, 2026, for PHESGO 600–600 mg pharmaceutical product (20,000 units, 10 ml vials) with a ceiling value of $16,891.92.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of April 9, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a $11,261.28 delivery order to Amerisourcebergen Drug Corp on April 8, 2026, for PHESGO 600–600 mg pharmaceutical product (20,000 units, 10 ml vials) under a firm fixed-price structure.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is April 29, 2026. The order carries no set-aside.</p>

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 1, 2026, for 20,000 units of PHESGO 600-600 MG in 10 ML vials, with a ceiling value of $5,630.64.</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of April 22, 2026. This delivery order was issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 16, 2026, for PHESGO 600-600 mg pharmaceutical product (20,000 units, 10 ml each) with a ceiling value of $5,630.64, issued under firm fixed-price terms with no set-aside.</p> <p>Place of performance is Conshohocken, PA. The order completion date is April 6, 2026.</p>

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 20, 2026, with a ceiling value of $22,522.56 for PHESGO 600-600 MG pharmaceutical product (20,000 units, 10 mL vials).</p> <p>Place of performance is Conshohocken, PA 19428. Ultimate completion date is March 13, 2026. The order is priced firm fixed price and carries no set-aside.</p>

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 24, 2026, with a ceiling value of $22,522.56 for 20,000 units of PHESGO 600-600 MG in 10 mL vials. The order is issued under the DLA Troop Support Medical IDC held by parent company Cencora, Inc., valued at up to $999,999,999.00 through December 2031, which supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Place of...

The Defense Logistics Agency issued a $8,494.69 delivery order to Amerisourcebergen Drug Corp on March 26, 2026, for 30,000 units of PHESGO 1,200-600MG in 15ML vials. This is a call against the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that provides global pharmaceutical support to military healthcare programs. Place of performance is Conshohocken, PA. The order carries a firm fixed price and an ultimate completion date of...

The Defense Logistics Agency issued a $16,891.92 delivery order to Amerisourcebergen Drug Corp on January 7, 2026, for PHESGO 600–600 MG pharmaceutical product (20,000 units, 10 mL). The order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), a comprehensive global pharmaceutical support vehicle enabling supply of pharmaceutical products and medical supplies to military healthcare programs. Place of performance is Conshohocken, PA. Ultimate completion date is...

On January 23, 2026, the Defense Logistics Agency awarded a delivery order valued at $5,630.64 to AmerisourceBergen Drug Corp for the supply of PHESGO 600-600 MG pharmaceutical product (20,000 units of 10ML vials). This firm fixed-price, competitively awarded contract carries an ultimate completion date of February 13, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen Drug Corp's parent company...